LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT – Neurocrine Biosciences, Inc. Transaction History
LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT portfolio value:
$201,000
portfolio value
LIVFORSAKRINGSBOLAGET SKANDIA, OMSESIDIGT quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -24.00% | -600 shares | -43K | $106.21 | 1.9K |
| Q2 2022 | share | Decrease | -13.79% | -400 shares | -28K | $97.48 | 2.5K |
| Q1 2022 | share | 0.00% | 0 shares | 25K | $93.75 | 2.9K | |
| Q4 2021 | share | Increase | +141.67% | 1.7K shares | 132K | $84.63 | 2.9K |
| Q3 2021 | share | 0.00% | 0 shares | -2K | $95.91 | 1.2K | |
| Q2 2021 | share | 0.00% | 0 shares | 0 | $97.32 | 1.2K | |
| Q1 2021 | share | 0.00% | 0 shares | 2K | $97.25 | 1.2K | |
| Q4 2020 | share | 0.00% | 0 shares | 0 | $95.85 | 1.2K | |
| Q3 2020 | share | 0.00% | 0 shares | -31K | $96.16 | 1.2K | |
| Q2 2020 | share | Increase | +71.43% | 500 shares | 85K | $122 | 1.2K |
| Q1 2020 | share | 0.00% | 0 shares | -14K | $86.55 | 700 | |
| Q4 2019 | share | Increase | 0.00% | 700 shares | 75K | $107.49 | 700 |